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OA features as they relate to M:L BMD
Medial TF cartilage damage (MRI) KL 3 or 4 Varus
Prevalence Odds ratio Prevalence Odds ratio Prevalence Odds ratio
Overall M:L BMD
Tertile 1
(0.74−1.24)
11/64
(17.2%)
Referent 19/64
(29.7%)
Referent 20/64
(31.3%)
Referent
Tertile 2
(1.24−1.39)
14/21
(66.7%)
9.6
(3.2−29.4)
17/21
(81.0%)
10.1
(3.0−33.9)
16/21
(76.2%)
7.0
(2.3−21.9)
Tertile 3
(1.40−1.71)
12/14
(85.7%)
28.9
(5.6–147.8)
12/14
(85.7%)
14.2
(2.9−69.6)
13/14
(92.9%)
28.6
(3.5–233.8)
p for trend <0.0001 p for trend <0.0001 p for trend <0.0001
Proximal M:L BMD
Tertile 1
(0.74−1.39)
11/68
(16.2%)
Referent 20/68
(29.4%)
Referent 20/68
(29.4%)
Referent
Tertile 2
(1.39−1.53
14/16
(87.5%)
36.3
(7.2–182.5)
13/16
(81.3%)
10.4
(3.2−29.4)
14/16
(87.5%)
16.8
(3.5−80.8)
Tertile 3
(1.54−1.82)
12/15
(80.0%)
20.7
(5.1−85.8)
15/15
(100%)
inﬁnity 15/15
(100%)
inﬁnity
p for trend <0.0001 p for trend <0.0001 p for trend <0.0001
Distal M:L BMD
Tertile 1
(0.73−1.09)
12/59
(20.3%)
Referent 20/59
(33.9%)
Referent 19/59
(32.2%)
Referent
Tertile 2
(1.09−1.17)
13/20
(65.0%)
7.3
(2.4−22.2)
13/20
(65.0%)
9.6
(3.2−29.4)
15/20
(75%)
6.3
(2.0−19.9)
Tertile 3
(1.17−1.57)
12/20
(60.0%)
5.9
(2.0−17.6)
15/20
(75.0%)
28.9
(5.6–147.8)
15/20
(75%)
6.3
(2.0−19.9)
p for trend =0.0011 p for trend <0.0001 p for trend =0.0010
Conclusions: In symptomatic KOA, increased ipsi-compartmental BMD
is most marked in the proximal 1 cm of peri-articular bone but extends
further. Tibial plateau proximal and distal bone behave similarly such that
both are associated with features of KOA. The 3 measures of M:L BMD
provide contrasting information that allow greater insight into the role of
bone in KOA. The attributes of these measures should be explored in
longitudinal settings.
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Purpose: The role of bone lesions in cartilage loss in knee osteoarthritis
(OA) is any area of great interest. Whether the initial lesion in OA occurs
in bone or cartilage remains unclear, as does the local relationship
between cartilage and bone lesions. Specialized MRI techniques afford
an opportunity to explore this issue in the human knee in vivo. The goals
of our study were: (1) to determine the frequency of subchondral bone
lesions within knee joint surface regions without any cartilage lesion; (2) to
determine the frequency of cartilage lesions within knee regions without
any bone lesion; (3) to determine the strength of the relationship between
cartilage and speciﬁc bone lesion severity.
Methods: Participants had knee OA in at least one knee, by deﬁnite
radiographic osteophytes. Knee MR images were acquired using coronal
T1-weighted spin-echo (SE), sagittal fat-suppressed dual-echo turbo SE,
and axial and coronal fat-suppressed T1-weighted 3D-fast low angle shot
(FLASH) sequences. Three regions (anterior, central, and posterior) of
each surface (medial and lateral femoral condyles, medial and lateral
tibial plateaus) were each scored separately for cartilage morphology
(CM, score range 0−6, in which 2 = solitary focal defect 1 cm in width),
subchondral bone edema (BE), bone cysts (BC), and bone attrition (BA)
using the WORMS method.
Results: The dominant knees of 196 participants (mean age 66, BMI 30,
78% women) were studied. Among tibiofemoral regions with CM< 2, the
prevalence of bone lesions ranged from 0−3%. Among regions without
any bone lesions (i.e. BE, BA, and BC=0), the prevalence of CM 2
ranged from 5% to 33%. Results for all medial tibial and femoral regions
are shown in the table. Within each region, among all knees, CM was
moderately to strongly correlated with each of the bone lesions. For
example, in the central medial femoral region, R (Spearman) for CM and
BE was 0.71 (95% CI 0.63, 0.78), for CM and BA 0.66 (95% CI 0.57,
0.73), and for CM and BC 0.43 (95% CI 0.31, 0.54), and in the central
medial tibial region, R for CM and BE was 0.76 (95% CI 0.70, 0.82), for
CM and BA 0.69 (95% CI 0.61, 0.76), and for CM and BC 0.49 (95% CI
0.38, 0.59).
Conclusions: In summary, in regions with healthy cartilage morphology,
the frequency of bone edema lesions, subchondral cysts, and bone
attrition was very low, whereas in regions with no bone lesions, the
frequency of cartilage lesions was substantially higher. These ﬁndings
are in keeping with the possibility that cartilage lesion development
may precede development of these bone lesions. Within each region,
worse cartilage morphology correlated moderately to strongly with greater
severity of each of the bone lesions.
Medial region Knees with CM< 2 Knees with BE, BA, and BC=0
# %BE> 0 %BA> 0 %BC> 0 # %CM 2
Femoral
anterior 110 1% 1% 0% 161 33%
central 98 1% 0% 0% 135 28%
posterior 134 2% 1% 1% 173 24%
Tibial
anterior 153 2% 0% 3% 166 11%
central 107 0% 2% 0% 139 24%
posterior 146 1% 0% 2% 170 16%
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Purpose: Human osteaoarthriits (OA) is a multi-factorial disease that
involves cartilage, bone and synovium. Epidemiological studies have
shown that it was age and sex-dependant, suggesting the importance
of sex hormones in OA pathophysiology. Estradiol (E2) has well known
effects on bone cells but little is known of its action on cartilage. Different
animal models have shown various conclusions on a possible prevention
of OA by E2. This action could be direct on chondrocytes, or through
the bone underlying the articular cartilage. Indeed, there is evidence of
a relationship between bone remodeling and cartilage degradation. Our
goal is to study the effects of E2 on meniscectomy in ovariectomized
C57/bl6 mice, in terms of cartilage loss, proteases expression and apop-
tosis. This ﬁrst part is followed by an ex vivo study on the direct effects
of E2 on cartilage explants.
Methods: 1. Ten week-old C57/Bl6 female mice underwent medial menis-
cectomy (MNX) of the right knee. Ovariectomy (OVX) was performed
followed by subcutaneous injection of E2 (15mg/kg/d), Pamidronate (PAM
30mg/kg/w) or PBS. Saggital sections in the medial compartment of
both femoro-tibial joints were performed at 6 weeks to evaluate cartilage
degradation using a simpliﬁed semi-quantitative OOCHAS OA grading
scale (from 0 to 6) and to measure bone histomorphometric parameters
in the proximal epiphysis of tibias. ADAMTS-4 and ADAMTS-5 expression
were studied in the cartilage by immunohistochemistry and chondrocyte
apoptosis by Tunel assay. 2. We cultured cartilage explants from femoral
heads in the presence of 10−6M & 10−8M E2 for 72 h with or without prior
stimulation with Il-1 for 24 h. The content of glycoaminoglycan (GAG) was
measured in the medium.
Figure 1.
Results: 1. Each group of mice had the same gain of weight during the
study. E2 and PAM prevented the OVX-related bone loss with an increase
of BV/TV. The OOCHAS score in MNX knees was similar regardless to
OVX (3 for both). PAM and E2 in OVX mice lowered the score at 1.7
and 2.2 respectively. MNX was associated with a signiﬁcant increased
expression of ADAMTS 4 and ADAMTS 5 expression. PAM and E2
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both signiﬁcantly decreased ADAMTS 4 and ADAMTS 5 expression ratio
from 60% to 35% (p=0.001) and 45% (p=0.013) and from 28% to 7%
(p=0.014) and 14% (p=0.03), respectively. They also decreased the
number of apoptotic chondrocytes. 2. Ex vivo, E2 prevents GAG release
induced by IL1 (Figure 1).
Conclusions: Our results suggest a preventive effect of E2 on cartilage
degradation triggered by MNX and OVX in mice. Preventing the increase
of bone remodeling by either E2 or PAM was associated with better
outcomes in terms of histological damage, proteases expression and
apoptosis. This emphasizes the importance of the relation between bone
and cartilage. However our ex vivo study suggests a possible anabolic
action of E2 on both chondrocytes and bone.
Cartilage/Chondrocyte Biology
140 INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR EXPRESSION
AND MICROSCOPIC SCORE IN NORMAL AND FOCALLY
OSTEOARTHRITIC EQUINE JOINTS
J.M. Dunleavy, M. Sharif, C.J. Fuller. University of Bristol, Bristol,
UNITED KINGDOM
Purpose: Much current research is focussed on implantation of tissue
engineered cartilage grafts to replace focally damaged cartilage. If macro-
scopically normal (MN) cartilage from grossly normal joints differs struc-
turally to that from focally damaged joints, and topographical variations
in structure exist across a joint, cartilage implants will only be successful
once methods of halting or reversing the degradative processes within
the entire joint environment are addressed, and site-speciﬁc grafts used.
The aim of this study was to compare expression of an anabolic cytokine
receptor and microscopic score of MN cartilage from six regions of grossly
normal equine joints and those with focal osteoarthritic (OA) lesions,
and to determine whether potential structural differences were related
to distance from an OA lesion.
Methods: MN cartilage was sampled from six sites on the mediodistal
metacarpal condyle at distances from the transverse ridge (TR, dashed
line in Figure 1), a common site of focal OA lesions. Samples from two
groups were compared: grossly normal joints (grade 0, n = 6 mean age
8.8±4.7 yrs) and joints with mild focal OA lesions restricted to the TR
(grade 1 n=7, mean age 10.6±1.7 yrs).
Figure 1.
Expression of the anabolic cytokine receptor, insulin-like growth factor-1
receptor (IGF-1R), was determined using immunohistochemistry. Mean
percentage of cells staining positively for IGF-1R in the superﬁcial zone
(%pos.S) and middle+deep zones (%pos.MD), and microscopic score
(modiﬁed Mankin) were determined for each site. Data were analysed
using one- and two-way ANOVA.
Results: There were no signiﬁcant differences in %pos.S, %pos.MD
or microscopic score between grade 0 and grade 1 joints at any site.
Topographical variations in %pos.MD were present in grade 1 joints.
There was a signiﬁcantly higher %pos.MD at site 4 compared to sites
2 and 3. A similar, but not statistically signiﬁcant pattern of %pos.MD
across the joint was demonstrated by grade 0 joints (Figure 2).
Figure 2. %pos.M+dat 6 sites of grade 0 and grade 1 equine distal
metacarpal condyles.
Grade 1 joints had signiﬁcant topographical variations in microscopic
score. Site 3 had a signiﬁcantly lower score than sites 1, 2, 4 and 5,
and site 4 had a signiﬁcantly higher score than site 6. A similar, though
statistically insigniﬁcant pattern of microscopic score across the joint was
demonstrated by grade 0 joints (Figure 3).
Figure 3. Modiﬁed mankin score at 6 sites of grade 0 and grade 1 equine
distal metacarpal condyles.
Conclusions: In contrast to the ﬁndings of our previous studies in-
vestigating catabolic cytokines and glycosaminoglycan loss, this study
indicated no differences between MN cartilage from grade 0 and grade 1
joints when measured by IGF-1R expression or microscopic score. This
may be due to a large variation in IGF-1R expression in grossly normal
joints, and the inability of the microscopic score to discriminate between
normal and very early OA cartilage. The topographical variation in ex-
pression of IGF-1R and microscopic score in MN cartilage from focally
damaged equine joints suggest that successful cartilage grafts need to
be site-speciﬁc. These data also reiterate the importance of sampling
site in studies contrasting variables between joints. IGF-1R expression
and microscopic score were not equally related to distance from lesion.
This ﬁnding, together with the lack of difference in MN cartilage between
Grade 0 and Grade 1 joints may indicate that it is not the presence of an
OA lesion, but other factors which are responsible for the topographical
variations seen.
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Purpose: Sox9 is a transcription factor that is essential for chondrocyte-
speciﬁc gene expression and chondrogenesis. However, the precise
mechanism of Sox9 activation is not fully understood. In this study, we
have identiﬁed TRPV4 by its ability to activate SOX9-dependent tran-
scription. Further, we analyzed the role of TRPV4 during chondrogenesis
in vitro.
Methods: A full-length cDNA library was constructed in mammalian
expression vector using mRNA of a murine chondrogenic cell line, ATDC5
by oligo-capping method. ATDC5 cells were co-transfected with each
cDNA clone and SOX9-dependent reporter plasmid, 4Col2E-Luc. Two
days later, luciferase activity was measured. cDNAs that produced more
than 2-fold induction of reporter activity relative to the parental plasmid,
were deﬁned as positive clones. The mRNA expression proﬁle of positive
clones during the chondrogenesis of ATDC5 cells was obtained by cDNA
microarray analysis. The mRNA expression of TRPV4 in various cell lines
and murine tissues was analyzed by RT-PCR. A pharmacological activator
of TRPV4, 4a-PDD was employed to examine the function of TRPV4. To
measure SOX9-dependent transcription, ATDC5 or a mesenchymal stem
cell line, C3H10T1/2 was transfected with 4Col2E-Luc. Cells were treated
with 0 to 360 nM 4a-PDD for 24 hs, then reporter activity was measured.
To examine the signaling pathway from TRPV4 to SOX9, ATDC5 cells
